国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

美國STAAR Surgical Company 
公司成立于1982年，總部位于美國加利福尼亞州，瑞士為其生產基地。STAAR瑞士公司出品的具有獨家專利保護的COLLAMER屈光晶體（ICL）是目前全球唯一已經通過美國FDA、歐洲Ce及中國SFDA認證的 可植入式后房隱形屈光接觸鏡。

STAARSurgical公司ICL植入手術開展有十余年歷史。1997年獲準在歐洲市場使用ICL開展視力矯正手術；2005年美國食品及藥物管理局（FDA）批準應用Visian ICL降低和治療近視；2006年8月ICL被中國SFDA正式批準使用。公司最新型號VISIAN　ICL－V4已經在全世界范圍內廣泛使用，手術總數超過八萬例，其中中國已完成了超過500例ICL手術。

VisianICL因術后極佳的視覺質量、可逆性（容易取出和替換）、保留自然的角膜組織完整、手術簡單、快捷、安全等突出優點為單純近視、近視伴散光以及遠視的矯正提供了一種全新的手術方法和理念。因而ICL用于治療各種高中度近視、遠視及散光，超越了激光治療的極限，是替代LASIK手術的最新、最安全的產品，具備廣闊的發展前景。

Enhancing Surgical Eye Correction with Collamer? IOLs and other Advancements
STAAR Surgical Company is at the vanguard of minimally invasive ophthalmic vision enhancement and technology. We believe in the importance of improving the efficiency, convenience, and comfort of corrective eye surgery for both medical professionals and patients. It is for this reason that we continually evaluate our existing products to ensure that we are providing the latest cataract, refractive error, and glaucoma treatments. From our patented COLLAMER lenses to Cruise Control, our unique new high vacuum surgery system, STAAR Surgical Company is responsible for some of the most revolutionary developments in ophthalmology.

Regarded as a technology leader in the surgical eye correction industry, STAAR Surgical Company was founded in 1982 when the intraocular lens (IOL) was still in its relative infancy. Although still an integral part of the company's portfolio, STAAR Surgical Company's product lines have expanded beyond cataract correction solutions to include lenses and medical devices for refractive and glaucoma surgery.

STAAR Surgical Company has revolutionized the industry with its development and use of Collamer. This unique lens material is used in the Afinity? line of intraocular lenses (IOLs), the Visian ICL, and the Visian TICL*. Each Collamer lens produced by STAAR Surgical Company is made from a material that not only is durable, but also replicates features of the eye's natural lens, creating high quality of vision and optimal biocompatibility.

STAAR Surgical Company has developed into a global surgical eye correction technology leader. To foster ongoing growth, we emphasize creativity, research, and development. Using these tools, STAAR Surgical Company plans to continue making advancements in technology, marketing, and financial strength.